Lowe syndrome

Loi, Mario
January 2006
Orphanet Journal of Rare Diseases;2006, Vol. 1, p16
Academic Journal
Lowe syndrome (the oculocerebrorenal syndrome of Lowe, OCRL) is a multisystem disorder characterised by anomalies affecting the eye, the nervous system and the kidney. It is a uncommon, panethnic, X-linked disease, with estimated prevalence in the general population of approximately 1 in 500,000. Bilateral cataract and severe hypotonia are present at birth. In the subsequent weeks or months, a proximal renal tubulopathy (Fanconi-type) becomes evident and the ocular picture may be complicated by glaucoma and cheloids. Psychomotor retardation is evident in childhood, while behavioural problems prevail and renal complications arise in adolescence. The mutation of the gene OCRL1 localized at Xq26.1, coding for the enzyme phosphatidylinositol (4,5) bisphosphate 5 phosphatase, PtdIns (4,5)P2, in the trans-Golgi network is responsible for the disease. Both enzymatic and molecular testing are available for confirmation of the diagnosis and for prenatal detection of the disease. The treatment includes: cataract extraction, glaucoma control, physical and speech therapy, use of drugs to address behavioural problems, and correction of the tubular acidosis and the bone disease with the use of bicarbonate, phosphate, potassium and water. Life span rarely exceeds 40 years.


Related Articles

  • Síndrome de Coffin-Lowry. García-Suárez, Adrián; Dansac-Rivera, Arie Benoit // Revista Medica del IMSS;nov/dic2014, Vol. 52 Issue 6, p693 

    Background: Typical clinical features of the Coffin-Lowry syndrome include facies with hypertelorism, small nose, wide mouth, full and everted lips; short stature, mental retardation, pectus deformity, mitral valve dysfunction, hippocampal and cerebellar involvement, hearing loss and spinal...

  • A locus for familial skewed X chromosome inactivation maps to chromosome Xq25 in a family with a female manifesting Lowe syndrome. Cau, Milena; Addis, Maria; Congiu, Rita; Meloni, Cristiana; Cao, Antonio; Santaniello, Simona; Loi, Mario; Emma, Francesco; Zuffardi, Orsetta; Ciccone, Roberto; Sole, Gabriella; Melis, Maria // Journal of Human Genetics;Nov2006, Vol. 51 Issue 11, p1030 

    In mammals, X-linked gene products can be dosage compensated between males and females by inactivation of one of the two X chromosomes in the developing female embryos. X inactivation choice is usually random in embryo mammals, but several mechanisms can influence the choice determining skewed X...

  • DNA missing in action: Deafness with X-linked agammaglobulinaemia is the clue to a contiguous gene deletion syndrome.  // Journal of Medical Genetics;Sep2007 Supplement 1, Vol. 44, pS58 

    An abstract of the study "DNA missing in action: Deafness with X-linked agammaglobulinaemia is the clue to a contiguous gene deletion syndrome," by Catherine McWilliam, C. Longman, J. Duncan and R. Hague is presented.

  • Renal Fanconi syndrome: taking a proximal look at the nephron. Klootwijk, Enriko D.; Reichold, Markus; Unwin, Robert J.; Kleta, Robert; Warth, Richard; Bockenhauer, Detlef // Nephrology Dialysis Transplantation;Sep2015, Vol. 30 Issue 9, p1456 

    Renal Fanconi syndrome (RFS) refers to the generalized dysfunction of the proximal tubule (PT) (Kleta R. Fanconi or not Fanconi? Lowe syndrome revisited. Clin J Am Soc Nephrol 2008; 3: 1244-1245). In its isolated form, RFS only affects the PT, but not the other nephron segments. The study of...

  • X-linked bipolar illness. Mendlewicz, J. // British Journal of Psychiatry;Oct92, Vol. 161, p569 

    A letter to the editor is presented in response to an article about X-linked dominant transmission of bipolar illness in the January 1992 issue.

  • X-linked bipolar illness. Hebebrand, J. // British Journal of Psychiatry;Oct92, Vol. 161, p570 

    A response by J. Hebebrand to a letter to the editor about an article on X-linked dominant transmission of bipolar illness in the January 1992 issue is presented.

  • Poor Tc-99m dimercaptosuccinic acid uptake, re-evaluation with Tc-99m MAG3 scintigraphy in Lowe syndrome. Koca, Gokhan; Atilgan, Hasan Ikbal; Demirel, Koray; Diri, Akif; Korkmaz, Meliha // Indian Journal of Nuclear Medicine;Oct2011, Vol. 26 Issue 4, p185 

    Tc-99m dimercaptosuccinic acid (DMSA) is filtered through the glomeruli and reabsorbed by the proximal tubules as low molecular weight proteins. In Lowe syndrome this mechanism is impaired and so poor DMSA uptake is seen. Poor DMSA uptake was shown in very few studies, but none mentioned normal...

  • Selective proximal renal tubular involvement and dyslipidemia in two cousins with oculocerebrorenal syndrome of Lowe. Rezan Topaloğlu; Michael Ludwig; Aslı Çelebi-Tayfur // Turkish Journal of Pediatrics;May/Jun2013, Vol. 55 Issue 3, p331 

    Oculocerebrorenal syndrome of Lowe (OCRL) is a rare, X-linked disorder characterized by congenital cataracts, neonatal or infantile hypotonia, seizures, cognitive impairment, and renal tubular dysfunction. In this article, we report two maternal cousins with OCRL with a hemizygous p.Ala788Asp...

  • A Boy with Dent-2 Disease. Vrljičak, Kristina; Batinić, Danica; Milošević, Danko; Nižić-Stančin, Ljiljana; Ludwig, Michael // Collegium Antropologicum;Sep2011, Vol. 35 Issue 3, p925 

    Dent-2 disease is an X-linked renal tubulopathy associated with mutations in OCRL gene. It is characterized by low-molecular weight proteinuria, hypercalciuria, nephrolithiasis/nephrocalcinosis and progressive renal failure. Patients may have some extra-renal symptoms of Lowe syndrome, such as...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics